We are live on ! Find out more
ZIVOW

Zivo Bioscience, Inc. Warrants
ZIVOW

Delisted

ZIVOW was delisted on the 24th of November, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Zivo Bioscience, Inc. Warrants in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $86.8K → $0 (-$86.8K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
–
Holders Change
-6
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
-$45.2K
2
Citadel Advisors
Citadel Advisors
Florida
-$7.97K
3
CH
CVI Holdings
Delaware
-$7.22K
4
VCA
Verdence Capital Advisors
Maryland
-$4.48K
5
UBS Group
UBS Group
Switzerland
-$13
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
1
Warberg Asset Management
Illinois
– -$45.2K -100,975 Closed
Citadel Advisors
2
Citadel Advisors
Florida
– -$7.97K -17,798 Closed
CH
3
CVI Holdings
Delaware
– -$7.22K -16,108 Closed
VCA
4
Verdence Capital Advisors
Maryland
– -$4.48K -10,000 Closed
UBS Group
5
UBS Group
Switzerland
– -$13 -30 Closed

ZIVOW Hedge Fund Activity: Q4 2023 in Review

0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q4 2023, worth a combined $0 — down 100% from $86.8K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ZIVOW and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Warberg Asset Management, exiting entirely with an estimated $45.2K sold.

  • 0 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q4 2023, down from 6 in Q3 2023.
  • Funds reported $0 of Zivo Bioscience, Inc. Warrants stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Zivo Bioscience, Inc. Warrants positions in Q4 2023 and 5 closed out, a net change of -5 holders.
  • The largest Zivo Bioscience, Inc. Warrants seller in Q4 2023 was Warberg Asset Management, an estimated $45.2K sold.

Based on aggregated 13F filings for Q4 2023.